Back

Clinical aspects: type 2 diabetes, cardiovascular disease and glucagon-like peptide-1 receptor agonists.

26 August 2018 (13:25 - 13:35)
Organised by:
Congress Presentation Part of: Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice Diabetes and the Heart Open Access ESC Congress 2018

About the speaker

Photo
Professor Marc Pfeffer

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice.
Doctor B. Scirica (Boston, US)
Slides Video
Presentation thumbnail
New insights into glucagon-like peptide-1 receptor agonist treatment considerations.
Professor S. Verma (Toronto, CA)
Slides Video
Presentation thumbnail
Perspective on glucagon-like peptide-1 receptor agonists in type 2 diabetes and cardiovascular disease: Interactive discussion.
Doctor B. Scirica (Boston, US) Professor M. Pfeffer (Boston, US) Professor S. Verma (Toronto, CA)
Slides Video

Access the full session

Session thumbnail
Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice

The Event

Event poster

ESC Congress 2018

26 August 2018 13:25 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI